A CLINICAL STUDY TO EVALUATE THE HEALING EFFECT OF MUNDI (SPHAERANTHUS INDICUS LINN.) GHRITA IN THE MANAGAMENT OF VIPÄ?DIKÄ?.

EVALUATION OF ROPANA KARMA OF MUNDI (SPHAERANTHUS INDICUS LINN.) GHRITA IN THE MANAGAMENT OF VIPÄ?DIKÄ?- A CLINICAL STUDY

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/03/032245

Enrollment

Registered

2021-03-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Mundi Ghritha: Dose- Quantity sufficient Duration- 30 days Mode of administration- External application Dosage form- Ghritha Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Patient fulfilling the diagnostic criteria Patient of either gender, from the age group of 18 - 70 Chronicity less than 1 year Willing to sign the consent form

Exclusion criteria

Exclusion criteria: Subject known case of systemic disease- Diabetes mellitus, Human immunodeficiency virus, Malignancy. Subjects associated with any dermatological condition. Patient known case of Vatarakta and other types of Kushthas. Patient on glucocorticosteroids, NSAIDs, Chemotherapy and Radiation therapy.

Design outcomes

Primary

Measure	Time frame
Healing action on vipadika Timepoint: Response assessed on 0th, 15th and 30th day	—

Secondary

Measure	Time frame
Improvement in the quality of lifeTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Aditi Gandhi

SDMCAH, Hassan

drprakashlhegde@sdmcahhassan.org9998180001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026